Post-Transplant Outcomes in High-Risk Compared with Non–High-Risk Multiple Myeloma: A CIBMTR Analysis
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2016
- Source ID
- 10.1016/j.bbmt.2016.07.007
Entities
People
- Amer Beitinjaneh
- Amrita Krishnan
- Anita D'Souza
- Baldeep Wirk
- Bipin N Savani
- Cindy J. Lee
- Cristina Gasparetto
- Dan Vogl
- David Vesole
- Emma C. Scott
- Gerhard C Hildebrandt
- Henry Fung
- Hillard M Lazarus
- Jason Tay
- Jean Yared
- Jennifer Le-Rademacher
- Jiaxing Huang
- Joseph Mikhael
- Kenneth Meehan
- Leona Holmberg
- Manish Sharma
- Matt Kalaycio
- Muneer H Abidi
- Muthalagu Ramanathan
- Parameswaran Hari
- Richard T. Maziarz
- Robert Kyle
- Saad Usmani
- Shaji K Kumar
- Siddhartha Ganguly
- Taiga Nishihori
- Tomer Mark
- Yago Nieto
Organizations
- Alexion Pharmaceuticals
- Amgen
- Bristol-Myers Squibb
- Celgene
- Chiron Corporation
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- Genzyme
- Gilead Sciences
- Health Research
- Health Resources and Services Administration
- Incyte
- Jazz Pharmaceuticals
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Miltenyi Biotec
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Otsuka (United States)
- Otsuka Pharmaceutical
- Pharmacyclics
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- Spectrum Pharmaceuticals
- St. Baldrick's Foundation
- Swedish Orphan Biovitrum
- Takeda Oncology
- United States Public Health Service
- University of Minnesota